Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$660M |
| 2 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$173M |
| 3 |
Altria Group
MO
|
+$145M |
| 4 |
Verizon
VZ
|
+$134M |
| 5 |
United Parcel Service
UPS
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
|
+$181M |
| 2 |
iShares MSCI Germany ETF
EWG
|
+$148M |
| 3 |
Apple
AAPL
|
+$127M |
| 4 |
abrdn Physical Gold Shares ETF
SGOL
|
+$106M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$92.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.3% |
| 2 | Financials | 12.48% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 11.3% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Sutro Biopharma
STRO
$425M
| $1.52M | ﹤0.01% |
7,023
+437
| +7% | +$72.4K |
|
|
CMRX
2677
DELISTED
Chimerix, Inc.
CMRX
| $1.52M | ﹤0.01% |
314,784
+7,077
| +2% | +$25.7K |
|
2678
MakeMyTrip
MMYT
$5.95B
| $1.5M | ﹤0.01% |
50,695
-14,048
| -22% | -$319K |
|
2679
Sony
SONY
$131B
| $1.49M | ﹤0.01% |
73,795
| – | – |
|
|
PLYA
2680
DELISTED
Playa Hotels & Resorts
PLYA
| $1.49M | ﹤0.01% |
250,315
+7,571
| +3% | +$35.1K |
|
2681
Rigel Pharmaceuticals
RIGL
$716M
| $1.46M | ﹤0.01% |
41,713
+1,682
| +4% | +$48.7K |
|
2682
Pliant Therapeutics
PLRX
$65M
| $1.45M | ﹤0.01% |
63,945
+933
| +1% | +$23.4K |
|
|
CASI
2683
DELISTED
CASI Pharmaceuticals
CASI
| $1.42M | ﹤0.01% |
48,011
+822
| +2% | +$17.9K |
|
|
SCPL
2684
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $1.4M | ﹤0.01% |
100,897
-2,270
| -2% | -$33K |
|
|
ISEE
2685
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.39M | ﹤0.01% |
201,169
-64
| -0% | -$410 |
|
2686
Taysha Gene Therapies
TSHA
$1.78B
| $1.39M | ﹤0.01% |
+52,232
| New | +$1.13M |
|
2687
Utah Medical Products
UTMD
$230M
| $1.38M | ﹤0.01% |
16,417
| – | – |
|
|
TCDA
2688
DELISTED
Tricida, Inc. Common Stock
TCDA
| $1.38M | ﹤0.01% |
195,077
+6,150
| +3% | +$47.2K |
|
2689
Altimmune
ALT
$597M
| $1.37M | ﹤0.01% |
121,521
+2,724
| +2% | +$32.1K |
|
2690
Comstock Resources
CRK
$3.91B
| $1.37M | ﹤0.01% |
313,622
+6,000
| +2% | +$29.7K |
|
2691
Digi International
DGII
$2.72B
| $1.37M | ﹤0.01% |
72,322
+3,700
| +5% | +$63.4K |
|
2692
Occidental Petroleum Corp Warrants
OXY.WS
$31B
| $1.36M | ﹤0.01% |
200,000
-12,492
| -6% | -$56.6K |
|
|
CASA
2693
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $1.34M | ﹤0.01% |
217,279
+3,593
| +2% | +$19K |
|
|
WMC
2694
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $1.34M | ﹤0.01% |
41,120
+6,326
| +18% | +$171K |
|
2695
Greenlight Captial
GLRE
$543M
| $1.34M | ﹤0.01% |
182,861
-3,489
| -2% | -$25.8K |
|
2696
W&T Offshore
WTI
$509M
| $1.34M | ﹤0.01% |
615,666
+13,689
| +2% | +$26.4K |
|
|
ETNB
2697
DELISTED
89bio
ETNB
| $1.33M | ﹤0.01% |
54,751
+14,703
| +37% | +$376K |
|
|
OYST
2698
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $1.32M | ﹤0.01% |
70,011
+1,303
| +2% | +$28.1K |
|
|
OCFT
2699
DELISTED
OneConnect Financial Technology
OCFT
| $1.31M | ﹤0.01% |
6,647
+209
| +3% | +$44K |
|
|
RAPT
2700
DELISTED
RAPT Therapeutics
RAPT
| $1.31M | ﹤0.01% |
8,293
+118
| +1% | +$25.7K |
|
Similar funds
Charles Schwab's Q4 2020 Portfolio in Review
As of Q4 2020, Charles Schwab held 3,457 positions worth $252B, up 16% from $217B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q4 2020 filing shows 113 new, 2,243 increased, 711 reduced and 62 closed positions. Its largest new stake was Vanguard FTSE Pacific ETF: 993,047 shares worth $79M. The largest sale was VanEck JP Morgan EM Local Currency Bond ETF, an estimated $181M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2020 buy was Vanguard FTSE Pacific ETF: 993,047 shares worth $79M.
- Charles Schwab added most to Tesla in Q4 2020, an estimated $660M increase.
- Charles Schwab's biggest Q4 2020 reduction was VanEck JP Morgan EM Local Currency Bond ETF, cutting an estimated $181M.
- Charles Schwab fully exited iShares MSCI Germany ETF in Q4 2020, selling an estimated $148M.
- Charles Schwab's ten largest holdings make up 17% of its $252B portfolio in Q4 2020.
- Charles Schwab opened 113 new positions and closed 62 in Q4 2020.
- Charles Schwab's portfolio value rose 16% quarter-over-quarter to $252B.
Based on Charles Schwab's 13F filing for Q4 2020, filed 16 Feb 2021.